Allergy and Infectious Diseases Research in Connecticut
Allergy and Infectious Diseases Research (93.855) awarded $341 million to recipients in Connecticut in 295 grants from fiscal 2021 to 2025, 1.6% of the program's national total. Yale Univ received the most, $275 million.
- Awarded in Connecticut$341 million
- Awards295
- Share of the program1.6%
- Rank among states15th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 132 | $65.0 million |
| FY 2022 | 125 | $59.0 million |
| FY 2023 | 131 | $62.8 million |
| FY 2024 | 158 | $69.7 million |
| FY 2025 | 143 | $84.3 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 224 | $275 million |
| University of Connecticut Health Center | Colleges and universities | 30 | $32.3 million |
| University of Connecticut Health Center | Colleges and universities | 10 | $11.3 million |
| L2 Diagnostics LLC | Small businesses | 13 | $8.5 million |
| Biopeptides Corp | Small businesses | 2 | $5.0 million |
| Abbratech Inc. | Small businesses | 2 | $1.5 million |
| Luna Bioscience, Inc. | Small businesses | 3 | $1.5 million |
| Connecticut Agricultural Experimental Station | State and local governments | 2 | $1.3 million |
| Quercus Molecular Design, LLC | Small businesses | 2 | $1.2 million |
| Enrich Biosystems Inc | Small businesses | 1 | $828,680 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Connecticut?
$341 million from fiscal 2021 to 2025, across 295 awards. Connecticut ranks 15th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Connecticut?
The largest recipient is Yale Univ, with $275 million in 224 awards. Next are University of Connecticut Health Center and University of Connecticut Health Center.
Can organizations in Connecticut apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies